68% of patients receiving Kymriah in the ELARA trial experienced a complete response, with an 86% overall response rate, along with a remarkable safety profile
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
The aim is to provide further insights into patients' lives in the effort to deliver better outcomes for people with psoriatic arthritis (PsA)
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
Successfully removed peanut from the child’s left lung through bronchoscopy
The key categories include intimate wellness, skincare & hair care
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Subscribe To Our Newsletter & Stay Updated
